Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Year: 2024
Type: article
Abstract: Engineered virus-like particles (eVLPs) are promising vehicles for transient delivery of proteins and RNAs, including gene editing agents. We report a system for the laboratory evolution of eVLPs that enables the discovery of eVLP variants with improved properties. The system uses barcoded guide RNAs loaded within DNA-free eVLP-packaged cargos to uniquely label each eVLP variant in a library, enabling the identification of desired variants following selections for desired properties. We applied this system to mutate and select eVLP capsids with improved eVLP production properties or transduction efficiencies in human cells. By combining beneficial capsid mutations, we developed fifth-generation (v5) eVLPs, which exhibit a 2-4-fold increase in cultured mammalian cell delivery potency compared to previous-best v4 eVLPs. Analyses of v5 eVLPs suggest that these capsid mutations optimize packaging and delivery of desired ribonucleoprotein cargos rather than native viral genomes and substantially alter eVLP capsid structure. These findings suggest the potential of barcoded eVLP evolution to support the development of improved eVLPs.
Source: Nature Biotechnology
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $12,290
Funders: Howard Hughes Medical Institute, U.S. Department of Health and Human Services, Bill and Melinda Gates Foundation, National Institutes of Health, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Eye Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Retinoids in Vision, G1705275158, Multiplex base/prime editors for in vivo selection of modified HSPCs in hemoglobinopathy, G2495830269, G3127212146, G3405342043, G349942176, Expanding the Scope of Base Editing, G4630203202, G5052434461, G63377500, G6479741818, G6855349143, G7486275663, Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics, Stem Cell and Transplantation Biology
OpenAlex ID: W4404333818
